| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing Direct > Direct Mail Response Rates Low? Eliminate These Mistakes |
|
Main Subject - Direct Mail Response Rates Low? Eliminate These Mistakes
Are your direct mail response rates lower than you expect? Check your sales letter or direct mail package against this checkli According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product st to uncover the reasons for your poor response. LIST You are mailing to people who are never likely t ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in buy You are not mailing to others in the same business who influence the buying decision Your list is out of date lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. r>
Your names and addresses are not formatted correctly for proper delivery Your list has job titles only, not names here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rong>FORMAT You are using the wrong format for your audience (self-mailers to professionals, for example) Y d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro our letter and brochure are not complete sales pitches in themselves Your liftnote or buckslip confuses your offer or mai ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc selling promise
ENVELOPE Your envelope gives too much away, so your prospects throw it away unopened easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi r>
Your mailing envelope looks like junk mail
Your package is addressed to “Occupant” and not to a person by name nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically g>MESSAGE Your letter lacks a strong, customer-focussed headline The opening line in your letter is not com and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ pelling You spell your prospective customer’s name incorrectly Your letter lacks specifics about product size, weigh ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi , color and other vital details You discuss product features but not customer benefits You talk too much about your ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a company and not enough about your reader You do not create enough desire Your letter lacks urgency You do not o dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod fer a guarantee OFFER You are offering the same thing that your competitors are offering Your offe cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin r is not specific Your offer is not exclusive Your offer is not relevant Your offer is not valuable Your o tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen fer is not unique Your offer is not useful CALL TO ACTION You do not ask for the order You as t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel k for the order, but too late in your letter You conclude by saying, “If you have any questions, don’t hesitate to contac ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust me”
You give too many ways to respond—or not enough REPLY DEVICE Your reply device is too clutter y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ed You do not tell prospects what to do to buy your product or service Your reply device is not postage-paid . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de >TIMING You are mailing at the wrong time of the year Your letter is arriving on the wrong day of the week< elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip br>
You are mailing too often, so prospects ignore you You are not mailing often enough, so prospects do not remember yo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Work At Home Moms - Their Numbers Grow B-A-L-A-N-C-I-N-G Your Juggling Act!
|